Nasdaq has decided to approve Bioservo Technologies' application to delist its shares (short name BIOS, ISIN code SE0009779085) from Nasdaq First North Growth Market.
The last day of trading on Nasdaq First North Growth Market is January 11, 2024.
For more information, please contact
Lawyer Olov Kling, liquidator, Konrad Advokater AB
phone: +46 70 210 13 79
olov.kling@konradadvokater.se
Mikael Wester, Marketing Director, Bioservo Technologies AB
phone: +468 21 17 10
mikael.wester@bioservo.com
About Bioservo Technologies
Bioservo Technologies AB (publ) is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy and efficient. The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health for workers and to improve quality of life for people with reduced muscle strength. Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Kista north of Stockholm.
FNCA Sweden AB is the company's Certified Adviser on Nasdaq First North Growth Market.
For more information, please visit www.bioservo.com